| Hans-Günter Meyer-Thompson | Benzodiazepine
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study.
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study.
Meyer M, Gygli F, Westenberg JN, Schmid O, Strasser J, Lang UE, Dürsteler KM, Vogel M.
Addict Sci Clin Pract. 2023 Jul 18;18(1):43. doi: 10.1186/s13722-023-00397-8. PMID: 37464432; PMCID: PMC10354905.